|
Endocrinopathy |
Timing of onset/diagnosis |
Expected results of investigations |
| Frequent |
|
|
|
PCOS |
Ages 15-25 (peripubertal onset) |
Rotterdam criteria (2+ of 3 needed): – Clinical or biochemical hyperandrogenism – Irregular menstrual cycles (oligomenorrhea/amenorrhea/anovulation) – Polycystic ovaries (transvaginal/pelvic US) and excluded other causes |
|
Idiopathic hirsutism |
Ages 15-25 (peripubertal onset) |
Normal androgen levels, diagnosis of exclusion |
|
Infrequent |
|
|
|
NCCAH |
Adolescence/peripubertal onset or early adulthood (more common in certain ethnic groups) |
– Morning serum 17-OHP >200 ng/d (>6 nmol/L) – Serum 17-OHP >1500 ng/dL (43 nmol/L) following a 250-microg ACTH stimulation test |
|
Classic 21-hydroxylase deficiency |
Congenital |
Very high neonatal 17-OHP (3500-5000 ng/dL [105-150 nmol/L]) on a heel-stick blood spot |
|
Ovarian hyperthecosis |
Onset in the third decade or later (usually postmenopausal) |
– Very high testosterone levels (>5.2 nmol/L [>150 ng/dL]) – Suppression of testosterone after gonadotropin-releasing hormone stimulation test – Diagnosis may be supported radiographically +/- histologic assessment of ovaries |
|
Drugs |
Not applicable |
Not applicable |
|
Rare |
|
|
|
Severe insulin resistance syndromes |
Adolescence or adulthood |
– Fasting serum insulin >150 pmol/L (21.6 microU/mL) and/or a peak insulin >1500 pmol/L (216 microU/mL) during OGTT – Significantly elevated serum testosterone leves (>5.2 nmol/L [>150ng/dL]) |
|
Androgen-secreting ovarian tumors |
Onset in the third decade or later (usually postmenopausal) |
– Very high testosterone levels (>5.2 nmol/L [>150 ng/dL]) – Unlikely to see suppression of testosterone after gonadotropin-releasing hormone stimulation test – May be visible on ovarian imaging (US/MRI) |
|
Androgen-secreting adrenal tumors |
Variable, but adrenal cancer peaks <5 years of age and in the fourth and fifth decades of life |
– Very high DHEAS levels (>700 microg/dL [18.9 micromol/L]) – Usually visible on non–contrast enhanced adrenal CT |
|
Cushing syndrome |
Variable, depending on cause |
– Morning cortisol >1.8 microg/dL (50 nmol/L) after a 1-mg dexamethasone suppression test – High 24-h urine free cortisol or late-night salivary cortisol |
|
Acromegaly |
Variable, but usually 40-45 years of age |
– Elevated serum insulin growth-like factor 1 – Growth hormone concentration >1 ng/mL 2 h after a 75-mg OGTT |
|
Gestational hyperandrogenism |
During pregnancy |
Elevated testosterone and/or DHEAS beyond normal range for pregnancy |
| 17-OHP, 17-hydroxyprogesterone; ACTH, adrenocorticotropic hormone; CT, computed tomography; DHEAS, dehydroepiandrosterone sulfate; MRI, magnetic resonance imaging; NCCAH, nonclassic 21-hydroxylase deficiency; OGTT, oral glucose tolerance test; PCOS, polycystic ovary syndrome; US, ultrasonography. | ||